News Conference News TCT 2016 RIBS VI: El SVB Absorb es Seguro en el Manejo de la Reestenosis Intra-stent pero No Supera al Stent Metálico Xience Michael O'Riordan November 08, 2016
News Conference News TCT 2016 RIBS VI: Absorb BVS Safe in In-Stent Restenosis but Fails to Best Xience Metallic Stent Michael O'Riordan November 08, 2016
News Conference News TCT 2016 RIBS VI:Absorb BVS 支架内再狭窄方面安全,但没有好过 Xience 金属支架 Michael O'Riordan November 08, 2016
Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
News Conference News TCT 2016 Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención Yael L. Maxwell November 02, 2016
News Conference News TCT 2016 Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties Yael L. Maxwell November 02, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
News Conference News TCT 2016 ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi November 01, 2016
Presentation TCT 2016 FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu October 31, 2016
Presentation TCT 2016 FORTITUDE: Nine-Month Clinical, Angiographic, and OCT Results With an Amorphous PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Antonio Colombo October 31, 2016
Presentation TCT 2016 MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth October 31, 2016
Presentation TCT 2016 FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid October 31, 2016
Presentation TCT 2016 REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley October 31, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2016 ILUMIEN III: OCT Imaging Matches IVUS but Fails to Beat Angiography for Stent Guidance in PCI Shelley Wood October 30, 2016
News Conference News TCT 2015 PLATFORM: FFRCT Reduces Costs Compared With Invasive Coronary Angiography October 13, 2015
News Conference News TCT 2015 CT-Derived FFR Could Improve Efficiency of Referral to ICA October 12, 2015
News Conference News TCT 2014 EVERBIO II: Angiographic Outcomes Similar for BVS, EES, BES September 17, 2014